Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Valuation in Depressed Mood, Anhedonia, and Anxiety [NA]
ClinicalTrials.gov entry notes that Virginia Tech is recruiting for a study on neurobehavioral components of reward and loss valuation relev…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligence Models
A clinical trial is evaluating artificial intelligence models to detect Autism Spectrum Disorder, Major Depressive Disorder and other mental…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Effects and Mechanisms of Change of Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder [NA]
This clinical trial update outlines ongoing research on internet-delivered cognitive behavioral therapy for generalized anxiety disorder, in…
-
FDA approval · 2025-09-02FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for a generic venlafaxine hydrochloride product.
-
FDA approval · 2025-08-29FDA Approved: ESCITALOPRAM — Original Application (Almatica Pharma LLC)
FDA approved the original application for escitalopram from Almatica Pharma LLC, making a generic escitalopram available. The approval cover…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety [NA]
A University of Texas at Austin trial is actively recruiting to evaluate whether respiratory training can treat transdiagnostic pathological…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Neuroimage-guided Dual-target Continuous Theta Burst Stimulation for Generalized Anxiety Disorder [NA]
Clinical trial status update indicates a study of neuroimage-guided dual-target continuous theta burst stimulation for generalized anxiety d…
-
FDA approval · 2025-08-21FDA Approved: PREGABALIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental ANDA for pregabalin, authorizing the marketing of a generic pregabalin product.
-
FDA approval · 2025-08-21FDA Approved: PREGABALIN — Supplemental Application (ScieGen Pharmaceuticals, Inc)
FDA approved a supplemental application for pregabalin from ScieGen Pharmaceuticals, Inc., confirming approval of the generic product under …
-
FDA approval · 2025-08-18FDA Approved: PREGABALIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Pregabalin submitted by Rising Pharma Holdings, Inc. under the approved ANDA.
-
FDA approval · 2025-08-15FDA Approved: PREGABALIN — Supplemental Application (Indoco Remedies Limited)
FDA approved a supplemental application for pregabalin from Indoco Remedies Limited, resulting in approval of a generic pregabalin product.
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Physical Exercise as Adjunctive Therapy for Affective Disorder and Anxiety
A Region Stockholm-sponsored trial is evaluating physical exercise as an adjunctive treatment for mood and anxiety disorders, with the study…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Teletherapy vs. In-Person Cognitive Behavioral Therapy for Generalized Anxiety Disorder [NA]
A clinical trial comparing teletherapy to in-person cognitive behavioral therapy for Generalized Anxiety Disorder is currently recruiting. T…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Biological and Psychological Markers After Intervention in Adults With GAD [NA]
A completed clinical trial examining biological and psychological markers after an intervention in adults with generalized anxiety disorder …
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Electroclinical Correlation of Anxiety [NA]
A recruiting clinical trial investigating electroclinical correlates of anxiety in participants with anxiety disorders, including generalize…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety [NA]
A recruiting update for a clinical trial evaluating internet-delivered cognitive-behavioral therapy for adolescents with autism and anxiety.
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Computerized Intervention Targeting the Error-Related Negativity and Balance N1 in Anxious Children [NA]
A completed clinical trial from Florida State University evaluated a computerized intervention targeting error-related negativity and N1 bal…
-
FDA approval · 2025-07-21FDA Approved: PREGABALIN — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application for pregabalin. The approval enables the marketing of a generic pregabalin pr…
-
FDA approval · 2025-07-21FDA Approved: PREGABLIN — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for pregabalin from Macleods Pharmaceuticals Limited, authorizing a generic version of the drug. Thi…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD [NA]
A clinical trial evaluating internet-based cognitive-behavioral therapy versus parent-coached CBT for obsessive-compulsive disorder and vari…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Just-In-Time Adaptive Interventions (JITAIs) in a Digital Mental Health Intervention for Middle-Aged and Older Adults With Chronic Pain [NA]
This is an update on an ongoing clinical trial evaluating Just-In-Time Adaptive Interventions (JITAIs) in a digital mental health program fo…
-
FDA approval · 2025-07-15FDA Approved: ESCITALOPRAM OXALATE — Original Application (Ascent Pharmaceuticals, Inc)
FDA approved escitalopram oxalate as a generic product for Ascent Pharmaceuticals, Inc (ANDA 215177). It is intended to be used for the same…
-
FDA approval · 2025-07-07FDA Approved: PREGABALIN — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approves a supplemental application for Pregabalin from Torrent Pharmaceuticals Limited, enabling the generic drug to be marketed.
-
FDA approval · 2025-07-07FDA Approved: PREGABALIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for pregabalin filed by Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: Mental Health Assessment and Prescribing by Alberta Pharmacists [NA]
A completed University of Alberta study investigates mental health assessment and prescribing practices by Alberta pharmacists for major dep…